Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial.

Giblett JP, Clarke S, Zhao T, McCormick LM, Braganza DM, Densem CG, O'Sullivan M, Adlam D, Clarke SC, Steele J, Fielding S, West NEJ, Villar SS, Hoole SP.

Am Heart J. 2019 Sep;215:41-51. doi: 10.1016/j.ahj.2019.05.013. Epub 2019 Jun 9.

PMID:
31277053
2.

Detection and Prediction of Bioprosthetic Aortic Valve Degeneration.

Cartlidge TRG, Doris MK, Sellers SL, Pawade TA, White AC, Pessotto R, Kwiecinski J, Fletcher A, Alcaide C, Lucatelli C, Densem C, Rudd JHF, van Beek EJR, Tavares A, Virmani R, Berman D, Leipsic JA, Newby DE, Dweck MR.

J Am Coll Cardiol. 2019 Mar 19;73(10):1107-1119. doi: 10.1016/j.jacc.2018.12.056.

3.

Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial.

Barbanti M, van Mourik MS, Spence MS, Icovelli F, Martinelli GL, Muir DF, Saia F, Bortone AS, Densem CG, van der Kley F, Bramlage P, Vis M, Tamburino C.

EuroIntervention. 2019 Jun 20;15(2):147-154. doi: 10.4244/EIJ-D-18-01197.

4.

Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.

Barbanti M, Baan J, Spence MS, Iacovelli F, Martinelli GL, Saia F, Bortone AS, van der Kley F, Muir DF, Densem CG, Vis M, van Mourik MS, Seilerova L, Lüske CM, Bramlage P, Tamburino C.

BMC Cardiovasc Disord. 2017 Oct 10;17(1):259. doi: 10.1186/s12872-017-0693-0.

5.

Report from the Annual Conference of the British Society of Echocardiography, November 2016, Queen Elizabeth II Conference Centre, London.

Steeds RP, Cowie MR, Rana BS, Chambers JB, Ray S, Srinivasan J, Schwarz K, Neil CJ, Scally C, Horowitz JD, Frenneaux MP, Pislaru C, Dawson DK, Rothwell OJ, George K, Somauroo JD, Lord R, Stembridge M, Shave R, Hoffman M, Ashley EA, Haddad F, Eijsvogels TMH, Oxborough D, Hampson R, Kinsey CD, Gurunathan S, Vamvakidou A, Karogiannis N, Senior R, Ahmadvazir S, Shah BN, Zacharias K, Bowen D, Robinson S, Ihekwaba U, Parker K, Boyd J, Densem CG, Atkinson C, Hinton J, Gaisie EB, Rakhit DJ, Yue AM, Roberts PR, Thomas D, Phen P, Sibley J, Fergey S, Russhard P.

Echo Res Pract. 2017 Sep 1;4(3):M1. doi: 10.1530/ERP-17-0046. No abstract available.

6.

Stunning and Right Ventricular Dysfunction Is Induced by Coronary Balloon Occlusion and Rapid Pacing in Humans: Insights From Right Ventricular Conductance Catheter Studies.

Axell RG, Giblett JP, White PA, Klein A, Hampton-Til J, O'Sullivan M, Braganza D, Davies WR, West NEJ, Densem CG, Hoole SP.

J Am Heart Assoc. 2017 Jun 6;6(6). pii: e005820. doi: 10.1161/JAHA.117.005820.

7.

Rapid Pacing-Induced Right Ventricular Dysfunction Is Evident After Balloon-Expandable Transfemoral Aortic Valve Replacement.

Axell RG, White PA, Giblett JP, Williams L, Rana BS, Klein A, O'Sullivan M, Davies WR, Densem CG, Hoole SP.

J Am Coll Cardiol. 2017 Feb 21;69(7):903-904. doi: 10.1016/j.jacc.2016.12.011. No abstract available.

8.

General anaesthesia vs. conscious sedation for transfemoral aortic valve implantation: a single UK centre before-and-after study.

Miles LF, Joshi KR, Ogilvie EH, Densem CG, Klein AA, O'Sullivan M, Martinez G, Sudarshan CD, Abu-Omar Y, Irons JF.

Anaesthesia. 2016 Aug;71(8):892-900. doi: 10.1111/anae.13522. Epub 2016 Jun 29.

9.

Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era.

Khawaja MZ, Sohal M, Valli H, Dworakowski R, Pettit SJ, Roy D, Newton J, Schneider H, Manoharan G, Doshi S, Muir D, Roberts D, Nolan J, Gunning M, Densem C, Spence MS, Chowdhary S, Mahadevan VS, Brecker SJ, Maccarthy P, Mullen M, Stables RH, Prendergast BD, de Belder A, Thomas M, Redwood S, Hildick-Smith D.

Catheter Cardiovasc Interv. 2013 Feb;81(2):366-73. doi: 10.1002/ccd.24534.

PMID:
22730270
10.

Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study.

Calvert PA, Obaid DR, O'Sullivan M, Shapiro LM, McNab D, Densem CG, Schofield PM, Braganza D, Clarke SC, Ray KK, West NE, Bennett MR.

JACC Cardiovasc Imaging. 2011 Aug;4(8):894-901. doi: 10.1016/j.jcmg.2011.05.005.

11.

Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity.

Calvert PA, Liew TV, Gorenne I, Clarke M, Costopoulos C, Obaid DR, O'Sullivan M, Shapiro LM, McNab DC, Densem CG, Schofield PM, Braganza D, Clarke SC, Ray KK, West NE, Bennett MR.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2157-64. doi: 10.1161/ATVBAHA.111.229237. Epub 2011 Jun 16.

PMID:
21680897
12.

Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody.

McAdoo SP, Densem C, Salama A, Pusey CD.

NDT Plus. 2011 Jun;4(3):208-210. No abstract available.

13.

Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology.

Klein AA, Webb ST, Tsui S, Sudarshan C, Shapiro L, Densem C.

Br J Anaesth. 2009 Dec;103(6):792-9. doi: 10.1093/bja/aep311. Review.

14.

The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy.

Saw J, Densem C, Walsh S, Jokhi P, Starovoytov A, Fox R, Wong G, Buller C, Ricci D, Mancini GB, Fung A.

JACC Cardiovasc Interv. 2008 Dec;1(6):654-9. doi: 10.1016/j.jcin.2008.08.017.

15.

Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis.

Hoole SP, White PA, Heck PM, Khan SN, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP.

Coron Artery Dis. 2009 Jun;20(4):253-9. doi: 10.1097/MCA.0b013e32832ac5ac.

PMID:
19440064
16.

Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans.

Hoole SP, Khan SN, White PA, Heck PM, Kharbanda RK, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP.

Eur J Heart Fail. 2009 May;11(5):497-505. doi: 10.1093/eurjhf/hfp040.

17.

Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial.

Fung AY, Saw J, Starovoytov A, Densem C, Jokhi P, Walsh SJ, Fox RS, Humphries KH, Aymong E, Ricci DR, Webb JG, Hamburger JN, Carere RG, Buller CE.

J Am Coll Cardiol. 2009 Mar 10;53(10):837-45. doi: 10.1016/j.jacc.2008.09.060.

18.

Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.

Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP.

Circulation. 2009 Feb 17;119(6):820-7. doi: 10.1161/CIRCULATIONAHA.108.809723. Epub 2009 Feb 2.

PMID:
19188504
19.

Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?

Densem CG, Ray M, Hutchinson IV, Yonan N, Brooks NH.

J Heart Lung Transplant. 2005 May;24(5):559-65.

PMID:
15896753
20.

Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression.

Fildes JE, Walker AH, Densem CG, Deiraniya AK, Hutchinson IV, Leonard CT, Yonan N.

J Heart Lung Transplant. 2005 Apr;24(4):406-10.

PMID:
15797740
21.

Radial approach to day case intervention in coronary artery lesions (RADICAL): a single centre safety and feasibility study.

Kumar S, Anantharaman R, Das P, Hobbs J, Densem C, Ansell J, Roberts DH.

Heart. 2004 Nov;90(11):1340-1. No abstract available.

22.

Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

Transpl Immunol. 2004 Nov;13(3):211-7.

PMID:
15381204
23.

A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation.

Densem CG, Mutlak AS, Pravica V, Brooks NH, Yonan N, Hutchinson IV.

Transpl Immunol. 2004 Nov;13(3):185-90.

PMID:
15381201
24.

Influence of IFN-gamma polymorphism on the development of coronary vasculopathy after cardiac transplantation.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

Ann Thorac Surg. 2004 Mar;77(3):875-80.

PMID:
14992891
25.

Haptoglobin phenotype correlates with development of cardiac transplant vasculopathy.

Densem CG, Wassel J, Cooper A, Yonan N, Brooks NH, Keevil B.

J Heart Lung Transplant. 2004 Jan;23(1):43-9.

PMID:
14734126
26.

Images in pacing. Fusion of permanent pacing leads.

Densem CG, Bennett DH, Davidson NC.

Europace. 2004 Jan;6(1):77-8. No abstract available.

PMID:
14697730
27.

Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

Transpl Immunol. 2003 Apr-Jun;11(2):223-8.

PMID:
12799207
28.
29.

Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

J Heart Lung Transplant. 2001 Dec;20(12):1265-73.

PMID:
11744409
30.

Tumour necrosis factor- a A2 polymorphism; a predisposing factor to non-ischaemic myocardial dysfunction?

Densem C, Hutchinson IV, Yonan N, Brooks NH.

J Heart Lung Transplant. 2001 Feb;20(2):159-160. No abstract available.

PMID:
11250236
31.

Haptoglobin polymorphism influences the development of cardiac transplant vasculopathy.

Densem CG, Wassel J, Brooks NH, Yonan N, Keevil B.

J Heart Lung Transplant. 2001 Feb;20(2):151. No abstract available.

PMID:
11250210
32.

The real cost of aspirin.

Burgess MI, Densem CG, Brooks NH, Levy RD, Lee HS.

Postgrad Med J. 2000 Nov;76(901):734-5.

33.

Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.

Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH.

J Heart Lung Transplant. 2000 Jun;19(6):551-6.

PMID:
10867335
34.

TGF-beta gene polymorphism does not influence the rise in creatinine following cardiac transplantation.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

Transpl Immunol. 1999 Dec;7(4):247-9. No abstract available.

PMID:
10638838
35.

Development of cryptogenic fibrosing alveolitis during pregnancy.

Densem C, Niven R, Barber P, Bishop P.

J R Soc Med. 1998 Nov;91(11):591-3. No abstract available.

36.

Development of echocardiography.

Densem CG, Burgess MI.

Hosp Med. 1999 Jan;60(1):71. No abstract available.

PMID:
10197110
37.

Prophylactic anticoagulation in chronic atrial flutter.

Densem CG.

Eur Heart J. 1999 Feb;20(4):317. No abstract available.

PMID:
10099928
38.

Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.

Densèm CG.

Am J Cardiol. 1999 Jan 1;83(1):140-1. No abstract available.

PMID:
10073808
39.

Impact of stenting on coronary angioplasty procedures.

Lee HS, Densem C, Levy RD, Bennett DH, Ray SG, Brooks NH.

Heart. 1998 Nov;80(5):505-8.

40.

Tumour necrosis factor and inflammatory bowel disease.

Densem CG.

Br J Surg. 1998 Jan;85(1):138. No abstract available.

PMID:
9462406
41.

Risk stratification of patients post-myocardial infarction.

Densem CG, Lee HS.

Br J Hosp Med. 1997 Jun 18-Jul 8;58(1):32-5. No abstract available.

PMID:
9337917
42.

Prognostic implications of elevated creatine kinase after coronary angioplasty.

Densem CG.

JAMA. 1997 May 28;277(20):1593. No abstract available.

PMID:
9168283

Supplemental Content

Loading ...
Support Center